Research ArticleArticle
Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay
Ravindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, Kathleen W. Mosure, Bokka Venkata Murali, T. Thanga Mariappan, Sandhya Mandlekar and Yurong Lai
Drug Metabolism and Disposition June 2017, 45 (6) 604-611; DOI: https://doi.org/10.1124/dmd.116.074740
Ravindranath Reddy Gilibili
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Sagnik Chatterjee
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Pravin Bagul
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Kathleen W. Mosure
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Bokka Venkata Murali
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
T. Thanga Mariappan
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Sandhya Mandlekar
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Yurong Lai
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Syngene International Ltd., Bangalore, India (R.R.G., S.C., P.B., B.V.M., T.T.M.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Princeton, New Jersey (K.W.M., Y.L.); and Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center (BBRC), Bangalore, India (S.M.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Coproporphyrin-I as Novel In Vitro Probe Substrate for MRP2
Ravindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, Kathleen W. Mosure, Bokka Venkata Murali, T. Thanga Mariappan, Sandhya Mandlekar and Yurong Lai
Drug Metabolism and Disposition June 1, 2017, 45 (6) 604-611; DOI: https://doi.org/10.1124/dmd.116.074740
Research ArticleArticle
Coproporphyrin-I as Novel In Vitro Probe Substrate for MRP2
Ravindranath Reddy Gilibili, Sagnik Chatterjee, Pravin Bagul, Kathleen W. Mosure, Bokka Venkata Murali, T. Thanga Mariappan, Sandhya Mandlekar and Yurong Lai
Drug Metabolism and Disposition June 1, 2017, 45 (6) 604-611; DOI: https://doi.org/10.1124/dmd.116.074740
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement